Folate and vitamin B 12 levels in abnormal pap smears: a case control study

Objective: This study aimed to explore the risk of abnormal cervical cytology in relation to serum folate and vitamin B12 levels, and demographic characteristics. Patients and methods: A case-control study was carried out among women attending the gynecology clinic for cervical cytology screening. At the follow-up clinic visit, fasting blood samples were collected from 103 cases with abnormal cervical cytology of the cervix and 175 controls with cytological normal smears and serum folate and vitamin B12 levels were measured. Data from cases and controls were compared. Logistic regression analysis was used to estimate the relative odds of abnormal cytology with increasing vitamin B12 levels. Results: There were no significant differences between cases and controls in demographic characteristics and mean folate levels (p > 0.05). The mean vitamin B12 level of cases was significantly lower than that of controls (p < 0.001). Dichotomized logistic regression analyses of vitamin B12 levels were significantly different (p < 0.001). The predicted percentages at a cut-off value of 0.5 were as follows: sensitivity 70.0%, specificity 74.6%, positive predictive value 71.8% and negative predictive value 72.6%. The logistic regression analysis of the 1st and the 4th quartiles of vitamin B12 levels showed a significant difference p < 0.001, OR: 1.525 (CI, 1.175-1.875). Conclusion: The results of this study suggest that lower vitamin B12 levels are associated with abnormal cervical cytology. It is recommended that women should consume not only folate-rich foods such as fruits and vegetables but also vitamin B12-rich foods such as meat, fish, milk products and eggs in a balanced way.

Pap smear; Preinvasive lesion; Cancer; Folate; Vitantin B12

[1] Parkin D.M.: "The global burden of cancer". Semin. Cancer Biol., 1998, 8, 219.

[2] Ball C., Madden J.E.: "Update on cervical cancer screenmg Current diagnostic and evidence-based management protocols". Postgrad. Med., 2003, 113, 59.

[3] Wright T.C. Jr.: "Pathogenesis and diagnosis of preinvasive lesions of the lower genital tract". In: Hoskins W.J., Perez C.A., Young R.C., Barakat R., Markmam M., Randall M. (eds.). Principles and Practice of Gynecologic Oncology. 4th edition, Philadelphia, Lippincott Williams and Wilkins, 2005, 627.

[4] Castle P.E., Wacholder S., Lorincz A.T., Scott D.R., Sherman M.E., Glass A.G. et al.: "A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women". J. Natl. Cancer 1nst., 2002, 94, 1406.

[5] Potischman N., Brinton L.A.: "Nutrition and cervical neoplasia". Cancer Causes Control., 1996, 7, 113.

[6] Working Group on Diet and Cancer of the Committee of Medical Aspects of Food and Nutrition Policy Department of Health: "Nutritional aspects of the development of cancer". 48th Report on Health and Social Subjects, Norwich, The Stationery Office, 1998, 136.

[7] Mason J.B., Choi S.W.: "Folate and carcinogenesis: developing a unifying hypothesis". Adv. Enzyme Regul., 2000, 40, 127.

[8] Mason J.B., Choi S.W.: "Effects of alcohol on folate metabohsm: implications for carcinogenesis". Alcohol, 2005, 35, 235

[9] Ubbink J.B., Verrnaak W.J., van der M.A., Becker P.J.: "Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia". Am. J. Clin. Nutr., 1993, 57, 47.

[10] Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt RA, Wang G., et al.: "Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage". Proc. Natl. Acad. Sci. USA., 1997, 94, 3290.

[11] Fenech M., Baghurst P., Luderer W., Turner J., Record S., Ceppi M., Bonassi S.: "Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability-results from a dietary intake and micronucleus index survey in South Australia". Carcinogenesis, 2005, 26, 991.

[12] Fowler B.M., Giuliano A.R., Piyathilake C., Nour M., Hatch K "Hypomethylation in cervical tissue: is there a correlation with folate status?". Cancer Epidemiol. Biomarkers Prev., 1998, 7, 901.

[13] Cheng P., Schmutte C., Cofer K.F., Felix J.C., Yu M.C., Dubeau L.: "Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis". Br. J. Cancer, 1997, 75, 396.

[14] Kim Y.I., Giuliano A., Hatch K.D., Schneider A., Nour M.A., Dallal G.E., et al.: " Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma". Cancer, 1994, 74, 893.

[15] Lajous M., Lazcano-Ponce E., Hernandez-Avila M., Willett W., Romieu I.: "Folate, vitamin B(6), and vitamin B(l2) intake and the risk of breast cancer among Mexican women". Cancer Epidemiol Biomarkers Prev., 2006, 15, 443.

[16] Heimburger D.C., Alexander C.B., Birch R., Butterworth C.E. Jr., Bailey W.C., Krumdieck C.L.: "Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial". JAMA, 1988, 259, 1525.

[17] BucklS;yD.I., McPherson R.S:, North CQ., Be_cker T.M.: "Dietary micronutrients and cervical dysplasia in southwestern American Indian women". Nutr. Cancer, 1992, 17, 179.

[18] Goodman M.T., McDuffie K., Hernandez B., Wilkens L.R., Selhub J.: "Case-control study of plasma folate, homocysteine, vitamin B(l 2), and cysteine as markers of cervical dysplasia". Cancer, 2000, 89, 376.

[19] Potischman N., Brinton L.A., Laiming V.A., Reeves W.C., Brenes M.M., Herrero R. et al.: "A case-control study of serum folate levels and invasive cervical cancer". Cancer Res., 1991, 51, 4785.

[20] Hernandez B.Y., McDuffie K., Wilkens L.R., Kamemoto L., Goodman M.T.: "Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12". Cancer Causes Control, 2003, 14, 859.

[21] Goodman M.T., McDuffie K., Hernandez B., Wilkens L.R., Bertram C.C., Killeen J. et al.: "Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia". Cancer Epidemiol. Biomarkers Prev., 2001, 10, 1275.

[22] Brock K.E., Berry G., Mock P.A., MacLennan R., Truswell A.S., Brinton L.A.: "Nutrients in diet and plasma and risk of in situ cervical cancer". J. Natl. Cancer Inst. 1988, 80, 580.

[23] Kanetsky P.A., Gammon M.D., Mandelblatt J., Zhang Z.F., Ramsey E., Dnistrian A. et al.: "Dietary intake and blood levels of lycopene: association with cervical dysplasia among non-Hispanic, black women". Nutr. Cancer, 1998, 31, 31.

[24] VanEenwyk J., Davis F.G., Colman N.: "Folate, vitamin C, and cervical intraepithelial neoplasia". Cancer Epidemiol. Biomarkers Prev., 1992, 1, 119.

[25] Ziegler R.G., Jones C.J., Brinton L.A., Norman S.A., Mallin K., Levine R.S. et al.: "Diet and the risk of in situ cervical cancer among white women in the United States". Cancer Causes Control, 1991, 2, 17.

[26] Kwasniewska A., Tukendorf A., Semczuk M.: "Folate deficiency and cervical intraepithelial neoplasia". Eur. J. Gynaecol. Oncol., 1997, 18, 526.

[27] Alberg A.J., Selhub J., Shah K.V., Viscidi RP., Comstock G.W., Helzlsouer K.J.: "The risk of cervical cancer in relation to serum concentrations of folate, vitamin Bl 2, and homocysteine". Cancer Epidemiol. Biomarkers Prev., 2000, 9, 761.

[28] Butterworth C.E. Jr., Hatch K.D., Macaluso M., Cole P., Sauberlich H.E., Soong S.J. et al.: "Folate deficiency and cervical dysplasia". JAMA, 1992, 267, 528.

[29] Butterworth C.E. Jr., Hatch K.D., Gore H., Mueller H., Krumdieek C.L.: "Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives". Am. J. Clin. Nutr., 1982, 35, 73.

[30] Childers J.M., Chu J., Voigt L.F., Feig! P., Tamimi H.K., Franklin E.W. et al.: "Chemoprevention of cervical cancer with folic acid: a phase III Southwest Oncology Group Intergroup study". Cancer Epidemiol. Biomarkers Prev., 1995, 4, 155.

[31] Thomson S.W., Heimburger D.C., Cornwell P.E., Turner M.E., Sauberlich H.E., Fox L.M. et al.: "Effect of total plasma homocysteine on cervical dysplasia risk". Nutr. Cancer, 2000, 37, 128.

[32] Eiserich J.P., van derVlietA., Handelman G.J., Halliwell B., Cross CE.: "Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction". Am. J. Clin. Nutr., 1995, 62 (suppl. 6), 1490.

[33] Giuliano A.R., Gapstur S.: "Can cervical dysplasia and cancer be prevented with nutrients?". Nutr. Rev., 1998, 56, 9.

[34] de Vet H.C., Knipschild P.O., Sturmans F.: "The role of sexual factors in the aetiology of cervical dysplasia". Int. J. Epidemiol., 1993, 22, 798.

[35] Chen Y.H., Huang L.H., Chen T.M.: "Differential effects of progestins and estrogens on long control regions of human papillomavirus types 16 and 18". Biochem. Biophys. Res. Commun., 1996, 224, 651.

[36] Autier P., Coibion M., Huet F., Grivegnee A.R.: "Transformation zone location and intraepithelial neoplasia of the cervix uteri". Br. J. Cancer, 1996, 74, 488.

[37] Sedjo R.L., lnserra P., Abrahamsen M., Harris R.B., Roe D.J., Baldwin S., Giuliano A.R.: "Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women". Cancer Epidemiol. Biomarkers Prev., 2002, 11, 353.